Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:39 pm Sale |
2022-12-31 | 13G | Energy Focus, Inc. EFOI |
Armistice Capital, LLC | 71,856 4.990% |
-17,818 (-19.87%) |
Filing History |
| 2023-02-14 12:35 pm Purchase |
2022-12-31 | 13G | Dynatronics Corporation DYNT |
Armistice Capital, LLC | 997,004 4.990% |
671,004 (+205.83%) |
Filing History |
| 2023-02-14 12:32 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,172,000 7.650% |
1,741,846 (+50.78%) |
Filing History |
| 2023-02-14 12:30 pm Unchanged |
2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,030,000 10.830% |
0 (Unchanged) |
Filing History |
| 2023-02-14 12:29 pm Purchase |
2022-12-31 | 13G | Clarus Therapeutics Holdings, Inc. CRXTQ |
Armistice Capital, LLC | 2,732,169 4.990% |
279,793 (+11.41%) |
Filing History |
| 2023-02-14 12:28 pm Purchase |
2022-12-31 | 13G | The Coretec Group Inc. CRTG |
Armistice Capital, LLC | 13,432,528 4.990% |
13,432,528 (New Position) |
Filing History |
| 2023-02-14 12:27 pm Sale |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 0 0.000% |
-9,572,000 (Position Closed) |
Filing History |
| 2023-02-14 12:24 pm Purchase |
2022-12-31 | 13G | Connexa Sports Technologies Inc. CNXA |
Armistice Capital, LLC | 32,310 9.990% |
32,310 (New Position) |
Filing History |
| 2023-02-14 12:23 pm Purchase |
2022-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP |
Armistice Capital, LLC | 66 9.990% |
66 (New Position) |
Filing History |
| 2023-02-14 12:23 pm Purchase |
2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 987,211 9.990% |
987,211 (New Position) |
Filing History |
| 2023-02-14 12:22 pm Purchase |
2022-12-31 | 13G | ContraFect Corporation CFRX |
Armistice Capital, LLC | 60,358 9.990% |
60,358 (New Position) |
Filing History |
| 2023-02-14 12:20 pm Purchase |
2022-12-31 | 13G | Conformis, Inc. CFMS |
Armistice Capital, LLC | 480,000 6.000% |
480,000 (New Position) |
Filing History |
| 2023-02-14 12:19 pm Purchase |
2022-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ |
Armistice Capital, LLC | 2,666,666 6.750% |
2,666,666 (New Position) |
Filing History |
| 2023-02-14 12:18 pm Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Armistice Capital, LLC | 1,165,709 4.990% |
1,165,709 (New Position) |
Filing History |
| 2023-02-14 12:16 pm Sale |
2022-12-31 | 13G | Bit Digital, Inc. BTBT |
Armistice Capital, LLC | 3,161,889 3.690% |
-1,053,963 (-25.00%) |
Filing History |
| 2023-02-14 12:15 pm Purchase |
2022-12-31 | 13G | Bruush Oral Care Inc. BRSH |
Armistice Capital, LLC | 44,917 9.990% |
44,917 (New Position) |
Filing History |
| 2023-02-14 12:06 pm Purchase |
2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 955,995 9.990% |
23,943 (+2.57%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
Armistice Capital, LLC | 1,298,965 5.700% |
1,298,965 (New Position) |
Filing History |
| 2023-02-14 12:03 pm Purchase |
2022-12-31 | 13G | Avinger, Inc. AVGR |
Armistice Capital, LLC | 52,627 9.990% |
52,627 (New Position) |
Filing History |
| 2023-02-14 12:02 pm Purchase |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Armistice Capital, LLC | 10,224,000 5.910% |
10,224,000 (New Position) |
Filing History |